Evidence map›Paper›PMID 41862630›Full record

ArticleJournal of human hypertension2026

Prevalence and clinical characteristics of secondary hypertension in young hypertensive tertiary care patients.

Jasmin Vesamo, Teemu J Niiranen, Karri Suvila

Abstract read
In one paragraph

Article in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jasmin VesamoDepartment of Internal Medicine, University of Turku, Turku, Finland. javesa@utu.fi.ORCID http://orcid.org/0009-0009-6449-6440
Teemu J NiiranenDepartment of Internal Medicine, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0002-7394-7487
Karri SuvilaDepartment of Internal Medicine, University of Turku, Turku, Finland.ORCID http://orcid.org/0000-0002-3543-9350

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current European guidelines recommend screening <30-year-old hypertensive patients for secondary hypertension, but the evidence behind this recommendation is limited. Our objective was to assess secondary hypertension prevalence and etiology among young adults and to determine the characteristics linked with secondary hypertension in these patients. We retrospectively studied 243 Finnish hypertensive adults aged 16-30 years (mean age 25.5 years; 49% women) evaluated at a tertiary care hospital in Finland between 2002 and 2023. Data were collected from electronic health records. Patients were classified under three hypertension subtypes: primary, secondary, or exogenic hypertension. We examined the association between participants characteristics and hypertension subtype (primary versus secondary) using logistic regression. A total of 133 patients had primary hypertension, while 98 patients had secondary hypertension. The most common causes of secondary hypertension were renal disease (n = 77) and sleep apnea (n = 13), whereas other causes were limited to 1-2 cases. Individuals with diabetes mellitus had odds of 2.79 (95% confidence interval [95% CI], 1.21-6.43; P = 0.02) for having secondary versus primary hypertension. A plasma creatinine increase of 1 mmol/l was associated with 1.03-fold (95% CI 1.01-1.04; P = 0.002) odds of secondary hypertension. Apart from renal disease and sleep apnea, other forms of secondary hypertension are extremely rare in young adults with hypertension. In this population, renal parenchymal disease and diabetes mellitus emerged as the most important risk factors for secondary hypertension. Extensive universal screening for secondary hypertension without suspicion of such condition for all hypertensive patients <30 years may be unnecessary.

Indexed as

Blood PressureHypertensionAdolescentAdultFemaleFinlandHumansMalePrevalenceRetrospective StudiesRisk FactorsTertiary Care CentersYoung Adult

Identifiers

PMID41862630
PMCPMC13068513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.